Merck's $6.7 billion Terns acquisition bolsters its oncology pipeline while reinforcing its strong margins, steadily growing ...
Biotechnology firm Infinimmune Inc. on Tuesday entered a collaboration with Merck & Co Inc. MRK to develop antibody ...
Pharmaceutical Technology on MSN
Merck KGaA acquires JSR chromatography business
The acquisition will add Belgium-based chromatography operations and a team of over 50 employees to Merck.
High-sensitivity sequencing of recurrent, cell-type–specific variants aims to strengthen causal inference versus germline ...
Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream ...
Merck (known as MSD outside the US and Canada) has agreed on a multi-year research collaboration with Quotient Therapeutics in a deal that could be worth up to $2.2bn. Through the collaboration, the ...
Somatic genetic mutations naturally accumulate over a lifetime, resulting in trillions of different genomes within an individual. Through its platform, Quotient interrogates patient tissue for these ...
Merck & Co advances global biopharmaceutical innovation The company maintains leadership in vaccines and oncology therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results